ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Asterias Biotherapeutics Common Series A

Asterias Biotherapeutics Common Series A (AST)

0,945
0,00
(0,00%)
Fermé 28 Novembre 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,945
Prix Achat
-
Prix Vente
-
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
0,945
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

AST Dernières nouvelles

Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury

FREMONT, Calif., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat...

BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech...

ALAMEDA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced the appointment...

Asterias Biotherapeutics Announces Fourth Patient Dosed in First-in-Human Clinical Study of Immunotherapy VAC2 in Non-Small C...

FREMONT, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cellular immunotherapies to treat cancer...

Asterias Biotherapeutics Reports Third Quarter Results

Clinical Programs Continue to ProgressRecent Transactions with affiliate of Novo Nordisk Increased Cash-on-Hand and Reduced Annual Operating ExpensesRecently Announced Definitive Merger Agreement...

BioTime and Asterias Biotherapeutics Enter Into Definitive Merger Agreement to Create Leading Cell Therapy Company

BioTime Acquires Two Clinical-Stage Cell Therapy Product Candidates Addressing Significant Unmet Needs in Spinal Cord Injury and Immuno-Oncology Asterias Stockholders to Receive 0.71...

BioTime Reports Third Quarter 2018 Financial Results and Provides Business Update

Industry Veteran Brian M. Culley Appointed as CEO Signed Agreement to Acquire Asterias Biotherapeutics, Inc. Received $43.2 Million from AgeX Sale Transaction with Juvenescence...

Asterias Biotherapeutics to Report Third Quarter 2018 Results on November 12, 2018

FREMONT, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat...

Asterias Biotherapeutics Announces Positive Outcome from Data Review from OPC1 Spinal Cord Injury Study

Meeting with Food and Drug Administration Remains on Track for End of 2018 FREMONT, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a...

Asterias Biotherapeutics Announces Facilities and IP License Option Agreements

FREMONT, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat...

FDA Accepts Asterias Biotherapeutics’ Request to Meet and Discuss Next Phase of Development for OPC1 Spinal Cord Injury Cli...

FREMONT, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
UMACUnusual Machines Inc
US$ 9,6501
(80,04%)
56,81M
MYNDMynd ai Inc
US$ 2,3055
(28,80%)
227,44k
OPTTOcean Power Technologies Inc
US$ 0,365
(25,04%)
212,82M
ETUT Rex 2X Long Ether Daily Target ETF
US$ 48,62
(19,61%)
54,45k
HCWCHealthy Choice Wellness Corp
US$ 1,72
(19,44%)
218,66k
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 1,03
(-19,53%)
449,97M
ETQT Rex 2X Inverse Ether Daily Target ETF
US$ 9,35
(-18,62%)
5,66k
ETHDProshares Ultrashort Ether ETF
US$ 21,075
(-18,23%)
308,53k
BOILProShares Ultra Bloomberg Natural Gas New
US$ 42,15
(-16,52%)
4,66M
BTCZT Rex 2X Inverse Bitcoin Daily Target ETF
US$ 5,86
(-12,80%)
284,6k
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 1,03
(-19,53%)
449,97M
OPTTOcean Power Technologies Inc
US$ 0,365
(25,04%)
212,82M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 26,98
(-4,09%)
84,24M
UMACUnusual Machines Inc
US$ 9,6501
(80,04%)
56,81M
EWZiShares MSCI Brazil ETF
US$ 26,48
(-3,57%)
39,71M
Aucune Discussion Trouvée
Ajouter une Discussion